{"id":55703,"date":"2023-01-25T07:58:56","date_gmt":"2023-01-25T07:58:56","guid":{"rendered":"https:\/\/siit.co\/guestposts\/?p=55703"},"modified":"2023-01-25T07:58:56","modified_gmt":"2023-01-25T07:58:56","slug":"pediatric-vaccines-market-size-top-manufacturers-global-demand-forecast-2023-2028","status":"publish","type":"post","link":"https:\/\/siit.co\/guestposts\/pediatric-vaccines-market-size-top-manufacturers-global-demand-forecast-2023-2028\/","title":{"rendered":"Pediatric Vaccines Market Size, Top Manufacturers, Global Demand, Forecast 2023-2028"},"content":{"rendered":"

The latest research study “Pediatric Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028<\/strong>” by IMARC Group, finds that the global pediatric vaccines market<\/a> size reached US$ 34.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 54.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.<\/strong><\/p>\n

Pediatric vaccines or immunizations refer to the medical supplies that create immunity in children, infants, and adolescents. They are utilized for the treatment, prevention, and management of diseases and are typically available in monovalent and multivalent variants. Pediatric vaccines are commonly used in cardiology, critical care, oncology, and pulmonology departments. They assist in protecting children from various serious illnesses, such as measles, brain swelling, polio, paralysis, diarrhea, and hepatitis. Pediatric vaccines are effective, promote a healthier life, are safe, and protect against infectious or noninfectious diseases.<\/p>\n

Request a Free PDF Sample for more detailed market insights: <\/strong>https:\/\/www.imarcgroup.com\/pediatric-vaccines-market\/requestsample<\/a><\/p>\n

Pediatric Vaccines Market Trends and Drivers:<\/strong><\/p>\n

The escalating prevalence of several chronic diseases is among the primary factor driving the pediatric vaccines market. Besides this, the development of effective and safe vaccination that eliminates and decreases dangerous illnesses that spread from child to child is further augmenting the market growth. Moreover, the introduction of new pediatric vaccines that aid in the treatment of adolescents and children with relapsing forms of multiple sclerosis (RMS) is also catalyzing the global market. Apart from this, the increasing need to promote public health and the extensive product utilization as a cost-effective means of advancing welfare across countries are acting as significant growth-inducing factors. Additionally, the elevating demand for conjugate vaccines that consist of antigens and have the ability to elicit immunological memory and reduce the asymptomatic carriage of the bacteria is also stimulating the market growth. Furthermore, the growing awareness toward early disease diagnosis and prevention, rising research and development (R&D) activities, and the launch of several policies by the government bodies to facilitate accurate and timely vaccination administration are anticipated to propel the pediatric vaccines market over the forecasted period.\u00a0<\/p>\n

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:<\/strong> https:\/\/www.imarcgroup.com\/pediatric-vaccines-market<\/a><\/p>\n

Pediatric Vaccines Market 2023-2028 Analysis and Segmentation:<\/strong><\/p>\n

Competitive Landscape:<\/strong><\/p>\n

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.<\/p>\n

Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd.<\/p>\n

The report has segmented the market on the basis of type, technology and application.
\nBreakup by Type:<\/strong><\/p>\n